Artigo de periodico

Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity (2019)

• Authors:
  • Ferreira, Rafael A. A. - Universidade Estadual de Campinas (UNICAMP)
  • Pauli, Ivani
  • Sampaio, Thiago S. - Universidade Estadual de Campinas (UNICAMP)
  • Souza, Mariana Laureano de
  • Ferreira, Leonardo Luiz Gomes
  • Magalhães, Luma Godoy
  • Rezende Junior, Celso O. - Universidade Estadual de Campinas (UNICAMP)
  • Ferreira, Rafaela S. - Universidade Federal de Minas Gerais (UFMG)
  • Andricopulo, Renata Krogh
  • Dias, Luiz C. - Universidade Estadual de Campinas (UNICAMP)
  • Andricopulo, Adriano Defini
• USP affiliated authors: ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; PAULI, IVANÍ - IFSC ; SOUZA, MARIANA LAUREANO DE - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; MAGALHÃES, LUMA GODOY - IFSC
• Unidade: IFSC
• DOI: 10.3389/fchem.2019.00798
• Subjects: DOENÇA DE CHAGAS; TRYPANOSOMA CRUZI; PLANEJAMENTO DE FÁRMACOS
• Keywords: Chagas disease; Trypanosoma cruzi; Cruzain; SAR; Medicinal chemistry; Synthesis; Inhibitors; Molecular docking
• Agências de fomento:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
    Processo FAPESP: 2011/13789-6
• Language: Inglês
• Imprenta:
  • Publisher place: Lausanne
  • Date published: 2019
• Source:
  • Título do periódico: Frontiers in Chemistry
  • ISSN: 2296-2646
  • Volume/Número/Paginação/Ano: v. 7, p. 798-1-798-21, Nov. 2019

Informações sobre o DOI: 10.3389/fchem.2019.00798 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: gold
• Licença: cc-by

---

Download do texto completo

Tipo	Nome	Link
	2980929.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  FERREIRA, Rafael A. A. et al. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, v. No 2019, p. 798-1-798-21, 2019Tradução . . Disponível em: https://doi.org/10.3389/fchem.2019.00798. Acesso em: 02 jun. 2024.

• APA

  Ferreira, R. A. A., Pauli, I., Sampaio, T. S., Souza, M. L. de, Ferreira, L. L. G., Magalhães, L. G., et al. (2019). Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, No 2019, 798-1-798-21. doi:10.3389/fchem.2019.00798

• NLM

  Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 jun. 02 ] Available from: https://doi.org/10.3389/fchem.2019.00798

• Vancouver

  Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 jun. 02 ] Available from: https://doi.org/10.3389/fchem.2019.00798

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics
• Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach
• Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach
• Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids
• Synthesis and anti-trypanosoma cruzi activity of 3-cyanopyridine derivatives
• Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum
• Chalcones and their B-aryl analogues as myeloperoxidase inhibitors: in silico, in vitro and ex vivo investigations
• QSAR and molecular docking for a series of inhibitors of the enzyme cruzain from Trypanosoma cruzi
• Chemoinformatics studies on a series of imidazoles as cruzain inhibitors
• Síntese total das marinoquinolinas A, B, C e E e análogos não-naturais